NOT-NS-21-011: Notice of Correction to Earliest Start Date for PAR-20-240 "NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed)"

Notice of Correction to Earliest Start Date for PAR-20-240 "NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed)"

Notice Number:

NOT-NS-21-011

Key Dates

Release Date:

October 26, 2020

Related Announcements

PAR-20-240 - NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed)

Issued by

National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

The purpose of this notice is to inform applicants of a correction to the Earliest Start Date for PAR-20-240 "NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed)". The Earliest Start Date has been corrected to read: December 2021, July 2022 and July 2023. Changes are shown in bold italics below.

Part 1. Overview Information

Key Dates

Earliest Start Date

July 2021, July 2022, July 2023

Part 1. Overview Information

Key Dates

Earliest Start Date

December 2021, July 2022, July 2023

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Michelle Jones-London, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-451-7966
Email: jonesmiche@ninds.nih.gov